Peyer James sold Sensei Biotherapeutics ($SNSE) shares eight times on the open market in the last year, for a total of $287,000. His most recent sale occurred on December 9, 2025. These transactions rank 7,652nd among 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 deals per insider. Peyer James recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Not found | S | Common Stock | 446 | $7.92 | 155,142.0000 | 1,261,290 | 0.29% | 0.04% |
| Dec. 9, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Not found | S | Common Stock | 2666 | $7.95 | 155,588.0000 | 1,261,290 | 1.68% | 0.21% |
| Dec. 9, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Not found | S | Common Stock | 395 | $8.04 | 155,588.0000 | 1,261,290 | 0.25% | 0.03% |
| Dec. 8, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Not found | S | Common Stock | 3105 | $8.59 | 158,254.0000 | 1,261,290 | 1.92% | 0.25% |
| Dec. 9, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Not found | M | Common Stock | 395 | $6.40 | 155,983.0000 | 1,261,290 | 0.25% | 0.03% |
| Dec. 9, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Not found | M | Stock Option (Right to Buy) | 395 | $0.00 | 0.0000 | 1,261,290 | 100.00% | 0.03% |
| Dec. 5, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Not found | S | Common Stock | 1745 | $12.29 | 161,401.0000 | 1,261,290 | 1.07% | 0.14% |
| Dec. 4, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Not found | S | Common Stock | 5000 | $9.06 | 177,654.0000 | 1,261,290 | 2.74% | 0.40% |
| Dec. 5, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Not found | S | Common Stock | 14508 | $11.40 | 163,146.0000 | 1,261,290 | 8.17% | 1.15% |
| Dec. 5, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Not found | S | Common Stock | 42 | $13.16 | 161,359.0000 | 1,261,290 | 0.03% | 0.00% |
| May 21, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 25,117,238 | 9999.99% | 0.08% |
| June 11, 2024 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 27,952,857 | 9999.99% | 0.07% |
| July 31, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Not found | D | Common Stock | 1587302 | $1.26 | 3,653,120.0000 | 0 | 30.29% | 0.00% |
| July 10, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Director | A | Stock Option (Right to Buy) | 14550 | $0.00 | 14,550.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Peyer James | Director | A | Common Stock | 4466 | $0.00 | 5,240,422.0000 | 0 | 0.09% | 0.00% |